Presentation TCT 2012 Should Rivaroxaban Be Used in STEMI Patients, and Does Choice of ADP Antagonist (with Rivaroxaban) Matter? Presenter: C. Michael Gibson October 25, 2012
Presentation TCT 2012 Primary PCI: Current Procedural Controversies and Decision-Making Presenter: Michel Le May October 25, 2012
Presentation TCT 2012 Carotid Intervention in a Complex Aortic Arch Presenter: Felix Damas de los Santos October 25, 2012
Presentation TCT 2012 Endovascular, Hybrid, and Open Approaches: Decision-making in Paravisceral and Thoracoabdominal Aneurysms Presenter: Joseph Ricotta II October 25, 2012
Presentation TCT 2012 The Changing Pattern of AAA Repair in the United States: Is There Still a Role for Elective Open Repair? Presenter: Zvonimir Krajcer October 25, 2012
Presentation TCT 2012 Part 2: Will the Transcatheter Valve Therapy Registry Transform US Regulatory Strategies? Presenter: David Holmes Jr October 25, 2012
Presentation TCT 2012 TAVR in a Patient with Severely Depressed Left Ventricular Ejection Fraction Presenter: Ariel Roguin October 25, 2012
Presentation TCT 2012 Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI! Presenter: Roxana Mehran October 25, 2012
Presentation TCT 2012 Racial Disparities in Interventional Cardiology in the United States: Behavior, Biology, or Bias? Presenter: A.J. Conrad Smith October 25, 2012
Presentation TCT 2012 Low-Profile Stent-Graft Delivery Systems Are Coming: What Do They Mean for the Field? Presenter: Zvonimir Krajcer October 25, 2012